Controlled Release of Tamsulosin from Nanopore-Forming Granules
![]() |
Seo, Seong-Mi
(Department of Polymer Engineering, Pukyong National University)
Lee, Hyun-Suk (Department of Information and Biomaterials, Hannam University) Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University) Lee, Ha-Young (Nanobiomaterials Laboratory, Korea Research Institute of Chemical Technology) Lee, Bong (Department of Polymer Engineering, Pukyong National University) Lee, Hai-Bang (Nanobiomaterials Laboratory, Korea Research Institute of Chemical Technology) Cho, Sun-Hang (Nanobiomaterials Laboratory, Korea Research Institute of Chemical Technology) |
1 | H.L. Hiltgrewe, Current trends in management of men with lower urinary tract wymptoms and benign prostatic hyperplasia, Urology, 51 (Supp. 4), 1-7 (1998) DOI ScienceOn |
2 | P. Narayan and A. Tewari, Overview of a-blocker therapy for benign prostatic hyperplasia, Urology, 51 (Supp. 4), 38-45 (1998) DOI ScienceOn |
3 | S.A. Kaplan, Minimally invasive alternative therapeutic options for lower urinary tract symptoms, Urology, 51 (Supp. 4), 32-37 (1998) DOI ScienceOn |
4 | M.P. O'Leary, Tamsulosin: current clinical experience, Urology, 58 (Supp. 1), 42-48 (2001) DOI ScienceOn |
5 | M.C. Michel, M.T. Flannery and P. Narayan, Worldwide experience with alfuzosin and tamsulosin, Urology, 58, 508-516 (2001) DOI ScienceOn |
6 | K. Harada, A. Kawaguchi, M. Ohmori and A. Fujimara, Antagonistic activity of tamsulosin against human vascular 1-adrenergic receptor, Clin. Pharmacol. Ther., 67, 405-412 (2000) DOI ScienceOn |
7 | M. Caine, S. Raz and M. Zeigler, Adrenergic and cholonergic receptors in the human prostate, prostatic capsule and bladder neck, Br. J. Urol., 47, 193-202 (1975) DOI ScienceOn |
8 | M. Caine, A. Pfau and S. Perlberg, The use of alpha adrenergic blockers in benign prostatic obstruction, Br. J. Urol., 48, 258-263 (1976) |
9 | H. Lepor, M. Baumann and E. Shapiro, The stereospecificity of LY253352 for alpha-1 adrenoreceptor binding sites in the brain and prostate, Br. J. Pharmacol., 95, 139-144 (1988) DOI ScienceOn |
10 | S. Kobayashi, R. Tang, E. Shapiro and H. Lepor, Characterization and localization of prostatic alphal adrenoreceptors using radioligand receptor binding on slide-mounted tissue section, J. Urol., 150, 2002-2006 (1993) DOI |
11 | G Khang, J. M. Rhee and H. B. Lee, Drug delivery system using osmotic pump : In High Efficiency Anticancer Drug Using Polymeric Biomaterials, H. B. Lee (Ed.), Munundang Publishing Co., Seoul, Korea, pp. 135-154 (2004) |
12 | S. Dutkiewicz and M. Filipek, Prazosin concentration monitoring in the treatment of prostatic adenoma, Int. Urol. Nephrol., 23, 143-150 (1991) DOI |
13 | K.A. Lyseng-Williamson, B. Jarvis and A.J. Wagstaff, Tamsulosin: an update of its role in the management of lower urinary tract symptoms, Drugs, 62, 135-167 (2002) DOI |
![]() |